Search by Drug Name or NDC
NDC 55150-0236-21 VECURONIUM BROMIDE 20 mg/1 Details
VECURONIUM BROMIDE 20 mg/1
VECURONIUM BROMIDE is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is VECURONIUM BROMIDE.
Product Information
| NDC | 55150-0236 |
|---|---|
| Product ID | 55150-236_26368338-338e-4438-8fc7-366e8e6f9bbb |
| Associated GPIs | 74200060102120 |
| GCN Sequence Number | 016619 |
| GCN Sequence Number Description | vecuronium bromide VIAL 20 MG INTRAVEN |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 19671 |
| HICL Sequence Number | 003744 |
| HICL Sequence Number Description | VECURONIUM BROMIDE |
| Brand/Generic | Generic |
| Proprietary Name | VECURONIUM BROMIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | VECURONIUM BROMIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | VECURONIUM BROMIDE |
| Labeler Name | Eugia US LLC |
| Pharmaceutical Class | Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206670 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55150-0236-21 (55150023621)
| NDC Package Code | 55150-236-21 |
|---|---|
| Billing NDC | 55150023621 |
| Package | 10 VIAL in 1 CARTON (55150-236-21) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (55150-236-02) |
| Marketing Start Date | 2018-12-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |